|Schedule An Appointment||Clinical Office Address|
|(801) 587-1549||Brain Institute
383 Colorow Drive
Salt Lake City, UT 84108
|(801) 583-2500||University Neuropsychiatric Institute
Child & Adolescent Psychiatry Research
501 Chipeta Way
Salt Lake City, UT 84108
|(801) 582-1565||Veterans Administration Medical Center
500 S Foothill Blvd
Salt Lake City, UT 84149
Dr. Kondo is a child psychiatrist and brain imaging researcher who works at the Brain Institute and University Neuropsychiatric Institute (UNI). His additional appointments include the Veterans Administration (VA) Salt Lake City Health Care System's Mental Illness Research, Education and Clinical Center (MIRECC), and he is a member of the Utah Science Technology and Research initiative (USTAR) faculty. His research areas inlcude clinical trials, and epidemiologic studies of the effects of altitude on regional rates of completed suicide, psychiatric disorders and substance abuse.
Dr. Kondo's clinical trials research currently focuses on Bipolar Disorder and Major Depressive Disorder, and the brain chemistry changes that are associated with them. Participants are either adolescents, or adult Veterans, and the neuroimaging method used is Magnetic Resonance Spectroscopy (MRS), performed on an FDA-approved clinical MRI scanner that does not use ionizing radiation. MRS is considered safe, which allows for scans to be performed pre-treatment, and then repeated post-treatment, to determine which brain chemiscals are altered as participants recover from either major depression or bipolar depression. The hypothesis underlying this work is that brain energy metabolism is compromised in some children and adults with mood disorders, and that targeting cortical bioenergetics is one potentially effective pharmaceutical treatment strategy.
The epidemiology studies Dr. Kondo works on utilize large, national mental illness and substance abuse data sets collected by the Center for Disease Control and Prevention (CDC). The CDC data are then combined with state and county altitude data from the Space Shuttle Radar Topography Mission (SRTM), conducted by the National Aeronautics and Space Administration (NASA). When analyzed together, the goal of this work is to investigate the association of increasing altitude with state and county rates of psychiatric symptoms, substance abuse and suicide. The underlying hypothesis is that the phenomenon known as "hypobaric hypoxia" may be an unrecognized contributor to the state and local burden of psychiatric illness and substance abuse. For example, local barometric pressure decreases exponentially with altitude. This means that at the altitude of Salt Lake City, Utah or Denver, Colorado, the barometric pressure is approximately 15% lower than at sea level. This results in an equivalent reduction in the partial pressure of oxygen in the inspired air (PIO2). Preclinical studies have shown that hypobaric hypoxia alters the levels of neurotransmitters, including serotonin and dopamine, that have been implicated in mental illness and substance abuse. Dr. Kondo's epidemiology work, and the Brain Institute's animal protocols, are designed to serve as a three-pronged translational research program, in which findings and novel hypotheses resulting from human brain imaging can be tested, and vice-versa.
Prior to joining the Brain Institute, USTAR and MIRECC research teams, Dr. Kondo's previous positions at the School of Medicine included: inpatient child and adult psychiatry at UNI, the Kidstar day treatment program for young children, the adolescent Teenscope day treatment program, and the Neurobehavior H.O.M.E. Program for children and adults with developmental disabilities. He formerly served as Medical Director of UNI's adolescent substance abuse intensive outpatient program. More information regarding Dr. Kondo's current research studies is available at the Internet website: UtahBrain.org.
Board Certification and Academic Information
|Academic Departments||Psychiatry - Assistant Professor (Clinical)
|Academic Divisions||Child Psychiatry
|Board Certification||American Board of Psychiatry & Neurology (Psychiatry)
American Board of Psychiatry & Neurology (Sub: Child/Adol)